CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit CAGRILINTIDE PEPTIDE 5MG 10MG VIAL UMBRELLA Labs What is Cagrilintide? GMP Plastic Buy Cagrilintide (10mg) Research Peptide Lab Grade Cagrilintide 5mg OP Labs (Formerly Oxford Peptides)